Avoro Capital Advisors LLC - Jun 30, 2025 SCHEDULE 13G Report for MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share
Symbol: MLTX
Shares outstanding: 63.8M shares
Disclosed Ownership: 4.15M shares
Ownership: 6.5%
Form type: SCHEDULE 13G
Date filed: 8/14/2025, 06:57 AM
Date of event: Jun 30, 2025
Next filing: Nov 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	6.5%	4.15M	4.15M	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	6.5%	4.15M	4.15M	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually